Tag: ESMINT 2026
Randomised clinical trials are ‘a methodology, not the oracle’
Following a session that saw neurointerventional experts deliberate the best and worst of randomised controlled trials (RCTs) in the field’s recent history, NeuroNews caught...
ESMINT announces new executive board for 2026–2028 term
Earlier this month, at the 18th European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), the society introduced its new...
Tenecteplase-related clot migration does not create a “clinical penalty” for stroke...
At this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), NeuroNews spoke with Jildaz Caroff (Bicêtre Hospital, Paris,...
